Paul W. Barone

Paul W. Barone has been at the Massachusetts Institute of Technology’s Center for Biomedical Innovation (CBI) since 2010. He is currently the Co-Director of the Biomanufacturing Program and Director of the Consortium on Adventitious Agent Contamination in Biomanufacturing (CAACB), both housed at MIT’s Center for Biomedical Innovation. In his role as Co-Director of the Biomanufacturing Program, Dr. Barone manages a variety of sponsored research activities related to biopharmaceutical manufacturing, including the development of novel analytical technologies for the rapid assessment of protein product quality, the development of a process for the continuous production of viral vectors, and the development of an online course on the principles of cell therapy manufacturing. Dr. Barone is also an instructor for 10.03x Making Medicines for Patients: The Principles of Biopharmaceutical Manufacturing.

Prior to joining CBI, Dr. Barone earned an M.S and Ph.D. in Chemical and Biomolecular Engineering from the University of Illinois, Urbana-Champaign and completed a Postdoc at MIT where his research focused on the development of novel nanoscale sensors for the detection of a variety of biologically relevant analytes, such as nitric oxide, glucose, and troponin.